96 related articles for article (PubMed ID: 29952922)
1. Stop TRPC5 in Kidney Disease: A Game Changer for Renal Allograft Protection?
Wang X; Reiser J
Transplantation; 2018 Jul; 102(7):1027-1029. PubMed ID: 29952922
[No Abstract] [Full Text] [Related]
2. Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain.
Fowler MA; Sidiropoulou K; Ozkan ED; Phillips CW; Cooper DC
PLoS One; 2007 Jun; 2(6):e573. PubMed ID: 17593972
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.
Sharma SH; Pablo JL; Montesinos MS; Greka A; Hopkins CR
Bioorg Med Chem Lett; 2019 Jan; 29(2):155-159. PubMed ID: 30538066
[TBL] [Abstract][Full Text] [Related]
4. TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels.
Plant TD; Schaefer M
Cell Calcium; 2003; 33(5-6):441-50. PubMed ID: 12765689
[TBL] [Abstract][Full Text] [Related]
5. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure.
Xu SZ; Zeng B; Daskoulidou N; Chen GL; Atkin SL; Lukhele B
Toxicol Sci; 2012 Jan; 125(1):56-68. PubMed ID: 21984481
[TBL] [Abstract][Full Text] [Related]
6. TRPC Channels in Health and Disease.
Tai Y; Yang S; Liu Y; Shao W
Adv Exp Med Biol; 2017; 976():35-45. PubMed ID: 28508311
[TBL] [Abstract][Full Text] [Related]
7. Renal physiology: TRPC5 inhibition to treat progressive kidney disease.
van der Wijst J; Bindels RJM
Nat Rev Nephrol; 2018 Mar; 14(3):145-146. PubMed ID: 29355170
[No Abstract] [Full Text] [Related]
8. TRPC1 as a negative regulator for TRPC4 and TRPC5 channels.
Kim J; Ko J; Myeong J; Kwak M; Hong C; So I
Pflugers Arch; 2019 Aug; 471(8):1045-1053. PubMed ID: 31222490
[TBL] [Abstract][Full Text] [Related]
9. Genistein potentiates activity of the cation channel TRPC5 independently of tyrosine kinases.
Wong CO; Huang Y; Yao X
Br J Pharmacol; 2010 Apr; 159(7):1486-96. PubMed ID: 20233211
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin increases expression and function of transient receptor potential canonical 5 channels.
Liu Y; Xu Y; Thilo F; Friis UG; Jensen BL; Scholze A; Zheng J; Tepel M
Hypertension; 2011 Aug; 58(2):317-24. PubMed ID: 21690481
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TRPC5 channels by intracellular ATP.
Dattilo M; Penington NJ; Williams K
Mol Pharmacol; 2008 Jan; 73(1):42-9. PubMed ID: 17925457
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane insertion of TRPC5 channels contributes to the cholinergic plateau potential in hippocampal CA1 pyramidal neurons.
Tai C; Hines DJ; Choi HB; MacVicar BA
Hippocampus; 2011 Sep; 21(9):958-67. PubMed ID: 20865744
[TBL] [Abstract][Full Text] [Related]
13. Opposite regulatory effects of TRPC1 and TRPC5 on neurite outgrowth in PC12 cells.
Heo DK; Chung WY; Park HW; Yuan JP; Lee MG; Kim JY
Cell Signal; 2012 Apr; 24(4):899-906. PubMed ID: 22201561
[TBL] [Abstract][Full Text] [Related]
14. Cryo-EM structure of TRPC5 at 2.8-Å resolution reveals unique and conserved structural elements essential for channel function.
Duan J; Li J; Chen GL; Ge Y; Liu J; Xie K; Peng X; Zhou W; Zhong J; Zhang Y; Xu J; Xue C; Liang B; Zhu L; Liu W; Zhang C; Tian XL; Wang J; Clapham DE; Zeng B; Li Z; Zhang J
Sci Adv; 2019 Jul; 5(7):eaaw7935. PubMed ID: 31355338
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
[TBL] [Abstract][Full Text] [Related]
16. TRPC5.
Zholos AV
Handb Exp Pharmacol; 2014; 222():129-56. PubMed ID: 24756705
[TBL] [Abstract][Full Text] [Related]
17. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.
Just S; Chenard BL; Ceci A; Strassmaier T; Chong JA; Blair NT; Gallaschun RJ; Del Camino D; Cantin S; D'Amours M; Eickmeier C; Fanger CM; Hecker C; Hessler DP; Hengerer B; Kroker KS; Malekiani S; Mihalek R; McLaughlin J; Rast G; Witek J; Sauer A; Pryce CR; Moran MM
PLoS One; 2018; 13(1):e0191225. PubMed ID: 29385160
[TBL] [Abstract][Full Text] [Related]
18. Functional Characterization of Transient Receptor Potential (TRP) Channel C5 in Female Murine Gonadotropes.
Beck A; Götz V; Qiao S; Weissgerber P; Flockerzi V; Freichel M; Boehm U
Endocrinology; 2017 Apr; 158(4):887-902. PubMed ID: 28324107
[TBL] [Abstract][Full Text] [Related]
19. Receptor-operated cation channels formed by TRPC4 and TRPC5.
Plant TD; Schaefer M
Naunyn Schmiedebergs Arch Pharmacol; 2005 Apr; 371(4):266-76. PubMed ID: 15902430
[TBL] [Abstract][Full Text] [Related]
20. Effect of non-steroidal anti-inflammatory drugs and new fenamate analogues on TRPC4 and TRPC5 channels.
Jiang H; Zeng B; Chen GL; Bot D; Eastmond S; Elsenussi SE; Atkin SL; Boa AN; Xu SZ
Biochem Pharmacol; 2012 Apr; 83(7):923-31. PubMed ID: 22285229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
